The appointment is effective from May 01, 2023 for five years
Atul Ltd. has appointed Rangaswamy Iyer as an Independent Director from May 1, 2023. Iyer has almost 4 decades of experience in Pharmaceuticals, Biologicals, Animal Health, Consumer Healthcare and strategic merger and acquisition (M&A).
He was Chief Financial Officer and Finance Director of Cyanamid India and then he transitioned to Wyeth Ltd and rose to become the Managing Director of Wyeth Ltd.
Iyer has been in consulting role in life sciences and has been a leading voice of the industry. He is an Advisor and Consultant to multinational and Indian pharma companies, private equity firms and investment bankers in areas of business strategy and business development (organic and inorganic). Currently he is senior advisor to LincoIn International, USA, an investment banker. He has to his credit several alliances and M&A deals which he spearheaded.
Iyer holds postgraduate degree in Commerce and is an MBA in Finance from the University of Mumbai.
Pfizer’s phase 3 studies of novel antibiotic combination offer new hope for patients with multidrug-resistant infections and treatment options
Merck partners with California-based research group to study catalysis innovation through machine learning
Philips and Masimo introduce advanced monitoring capabilities to Philips high acuity patient monitors
Subscribe To Our Newsletter & Stay Updated